Nav: Home

Minimally invasive surgery leads to worse survival for cervical cancer patients

October 31, 2018

  • 'We recommend only using open surgery for cervical cancer'
  • 60 percent of cervical cancer hysterectomies are performed minimally invasively
  • In 2018, around 13,240 women will be diagnosed with cervical cancer in the U.S.
CHICAGO --- Minimally invasive hysterectomy, a popular procedure for early-stage cervical cancer, turns out to result in worse overall survival for cancer patients than traditional open surgery, reports a new national study from Northwestern Medicine and other institutions.

Among women undergoing minimally invasive surgery, the risk of death within four years was 9.1 percent as compared to 5.3 percent in the open surgery group, a 3.8 percent difference. This equates to patients being about 1.65 times more likely to die over this time frame than if they received open surgery.

"At this point, we would recommend only using open surgery to perform a radical hysterectomy for cervical cancer," said co-senior author Dr. Shohreh Shahabi, chief of gynecologic oncology at Northwestern University Feinberg School of Medicine and a Northwestern Medicine physician.

The study will be published in the New England Journal of Medicine Oct. 31.

The results of a prospective, randomized clinical trial published in the same issue of the New England Journal of Medicine also supports only using open surgery going forward, added Shahabi. She is the John and Ruth Brewer Professor of Gynecology and Cancer Research and a member of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University.

"Although based on our analyses we cannot explain why minimally invasive surgery is associated with inferior overall survival, possible explanations include the potentially limited extent of tumor removal during minimally invasive surgery, or that tools used during minimally invasive hysterectomy may inadvertently disseminate tumor cells," Shahabi said.

"It is important to note these results are specific to cervical cancer, and minimally invasive surgery is still a great option for other surgeries and cancers," Shahabi noted.

This study was a retrospective study that looked at patients in the National Cancer Database from 2010 to 2013. This database includes 70 percent of all new cancer diagnoses in the United States. The study authors identified 2,461 patients with stage IA2 or IB1 cervical cancer who were treated with a radical hysterectomy. About half of these women had open surgery and half had minimally invasive surgery. They also used the Surveillance, Epidemiology, and End Results database to look at trends in survival prior to and after the adoption of the minimally invasive approach to radical hysterectomy.

In 2018, around 13,240 women will be diagnosed with cervical cancer in the United States, noted co-lead author Dr. Daniel Magul, who worked on the study in Shahabi's lab as a student at Feinberg and now is a resident physician at University Hospital in Cincinnati.

Minimally invasive radical hysterectomy first started to become popular around 2006. Over course of the study -- from 2010 to 2013 -- minimally invasive radical hysterectomies became progressively more common. In 2010, just more than a third of radical hysterectomies were performed with minimally invasive surgery, but by 2013, nearly 60 percent were performed minimally invasively.

Open surgery is performed with a large laparotomy incision in the middle of the abdomen. Recovery from this surgery generally requires several days in the hospital. Minimally invasive surgery is performed by inflating the abdomen with gas and operating through very small incisions using a camera and long instruments or a robot. The recovery time for minimally invasive surgery is much shorter, and patients can usually go home either the same day or day after their procedure.
Other institutions participating in the study include Harvard Medical School, M.D. Anderson Cancer Center, University of Wisconsin School of Medicine and Public Health and the Herbert Irving Comprehensive Cancer Center at Columbia University.

Other Northwestern authors on the study include Dr. Masha Kocherginsky, co-senior author, Dr. Emma Barber and Dr. Amy Alexander.

More News at Northwestern Now

Find experts on our Faculty Experts Hub

Follow @NUSources for expert perspectives

Northwestern University

Related Cervical Cancer Articles:

25 years of learning to combat cervical cancer
A recent paper from the lab of Professor Sudhir Krishna at the National Centre for Biological Sciences, Bangalore, reviews the progress made in cervical cancer research over the past 25 years.
Cervical cancer screening numbers drop off in women 45-65
Virtually all cervical cancers are caused by HPV, and much of the attention in recent years has focused on preventing infections in younger women through HPV vaccination.
Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.
Cost-effectiveness analysis of 12 cervical cancer screenings
This cost-effectiveness analysis incorporates women's preferences and estimates quality of life and economic outcomes for 12 cervical cancer screening strategies.
Urine test could prevent cervical cancer
Urine testing may be as effective as the smear test at preventing cervical cancer, according to new research by University of Manchester scientists.
Cervical cancer subtype rising in some sub-populations
A new study reports that a type of cervical cancer that is less amenable to Pap testing is increasing in several subpopulations of women, pointing to the growing importance of human papillomavirus (HPV) testing and vaccination
Cervical cancer is more aggressive when human papillomavirus is not detected
Cervical cancer negative for the human papillomavirus (HPV) is rare but more aggressive: it is more frequently diagnosed at advanced stages, with more metastasis and reduced survival.
USPSTF recommendation statement on screening for cervical cancer
The US Preventive Services Task Force (USPSTF) has updated its recommendations regarding screening for cervical cancer, with the recommendations and type of screening method varying depending on the woman's age and other factors.
Does HPV vaccination prevent the development of cervical cancer?
New evidence published today in the Cochrane Library shows that human papilloma virus (HPV) vaccines protect against cervical lesions in young women, particularly in those who are vaccinated between the ages of 15 and 26.
There's a better way to screen for cervical cancer
A new study in the Journal of the National Cancer Institute indicates that high-quality cervical cancer screening can be done effectively using a completely automated approach.
More Cervical Cancer News and Cervical Cancer Current Events

Top Science Podcasts

We have hand picked the top science podcasts of 2019.
Now Playing: TED Radio Hour

In & Out Of Love
We think of love as a mysterious, unknowable force. Something that happens to us. But what if we could control it? This hour, TED speakers on whether we can decide to fall in — and out of — love. Guests include writer Mandy Len Catron, biological anthropologist Helen Fisher, musician Dessa, One Love CEO Katie Hood, and psychologist Guy Winch.
Now Playing: Science for the People

#543 Give a Nerd a Gift
Yup, you guessed it... it's Science for the People's annual holiday episode that helps you figure out what sciency books and gifts to get that special nerd on your list. Or maybe you're looking to build up your reading list for the holiday break and a geeky Christmas sweater to wear to an upcoming party. Returning are pop-science power-readers John Dupuis and Joanne Manaster to dish on the best science books they read this past year. And Rachelle Saunders and Bethany Brookshire squee in delight over some truly delightful science-themed non-book objects for those whose bookshelves are already full. Since...
Now Playing: Radiolab

An Announcement from Radiolab